Charles River Labs has updated its Tumor Model Compendium database with the addition of new tumor models for early-stage oncology research.
The latest updates include gastric and liver models, and new molecular data for leukemia, liver cancer, lymphoma, breast cancer and ovarian cancer. The compendium allows oncology researchers to access data that can identify the most appropriate tumor models. This hope is it will lead to more targeted study design from the beginning that could save time and money before clinical trials begin.
Charles River’s compendium includes models from a wide range tumor subtypes for both in vivo and in vitro oncology research.